Literature DB >> 8396680

Specificity analysis of human CD4+ T-cell clones directed against human herpesvirus 6 (HHV-6), HHV-7, and human cytomegalovirus.

M Yasukawa1, Y Yakushijin, M Furukawa, S Fujita.   

Abstract

In order to clarify antigenic variations among various isolates of human herpesvirus 6 (HHV-6) and cross-reactivity among HHV-6, HHV-7, and human cytomegalovirus (HCMV) in the T-cell immune response, the antigenic specificity of the proliferative response mediated by 232 CD4+ human T-cell clones directed against HHV-6, HHV-7, or HCMV was examined. The results obtained were as follows. (i) Although the majority of T-cell clones directed against HHV-6 proliferated in response to stimulation with all strains of HHV-6 used (U1102, Z29, SF, and HST), 7% (8 of 122) of the T-cell clones showed distinct patterns of proliferative response against strain U1102 (group A) and other strains of HHV-6 (group B). (ii) Of 99 T-cell clones, 71 showed a distinct proliferative response to HHV-6 and HHV-7, whereas 28 proliferated in response to stimulation with both HHV-6 and HHV-7. (iii) A small number of T-cell clones (9 of 232) showed cross-reactivity against HHV-6 and HCMV, and 2 of the 232 clones were reactive with HCMV as well as with HHV-6 and HHV-7. (iv) The specificity of gamma interferon production by T-cell clones following the stimulation with virus antigen was identical to that of their proliferative response. These data thus indicate the presence of antigenic variations among isolates of HHV-6 and also epitopes common to HHV-6 and HHV-7 and to HHV-6, HHV-7, and HCMV which are recognized by CD4+ T cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8396680      PMCID: PMC238049     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  Polymorphism of human herpesvirus 6 DNA from five Japanese patients with exanthem subitum.

Authors:  H Kikuta; H Lu; S Matsumoto; S F Josephs; R C Gallo
Journal:  J Infect Dis       Date:  1989-09       Impact factor: 5.226

2.  Hepatitis due to human herpesvirus-6.

Authors:  S Dubedat; N Kappagoda
Journal:  Lancet       Date:  1989-12-16       Impact factor: 79.321

3.  Differential in vitro activation of CD4+CD8- and CD8+CD4- herpes simplex virus-specific human cytotoxic T cells.

Authors:  M Yasukawa; A Inatsuki; Y Kobayashi
Journal:  J Immunol       Date:  1989-09-15       Impact factor: 5.422

4.  Characteristics of human herpesvirus-6.

Authors:  C Lopez; P Pellett; J Stewart; C Goldsmith; K Sanderlin; J Black; D Warfield; P Feorino
Journal:  J Infect Dis       Date:  1988-06       Impact factor: 5.226

5.  Human herpesvirus 6 is closely related to human cytomegalovirus.

Authors:  G L Lawrence; M Chee; M A Craxton; U A Gompels; R W Honess; B G Barrell
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

6.  The spectrum of clinical and laboratory findings resulting from human herpesvirus-6 (HHV-6) in patients with mononucleosis-like illnesses not resulting from Epstein-Barr virus or cytomegalovirus.

Authors:  T A Steeper; C A Horwitz; D V Ablashi; S Z Salahuddin; C Saxinger; R Saltzman; B Schwartz
Journal:  Am J Clin Pathol       Date:  1990-06       Impact factor: 2.493

7.  Human herpesvirus 6 (HHV-6) variant B accounts for the majority of symptomatic primary HHV-6 infections in a population of U.S. infants.

Authors:  S Dewhurst; K McIntyre; K Schnabel; C B Hall
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

8.  Identification of human herpesvirus-6 as a causal agent for exanthem subitum.

Authors:  K Yamanishi; T Okuno; K Shiraki; M Takahashi; T Kondo; Y Asano; T Kurata
Journal:  Lancet       Date:  1988-05-14       Impact factor: 79.321

9.  Characterization of a new strain of HHV-6 (HHV-6SF) recovered from the saliva of an HIV-infected individual.

Authors:  J A Levy; F Ferro; E T Lennette; L Oshiro; L Poulin
Journal:  Virology       Date:  1990-09       Impact factor: 3.616

10.  Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders.

Authors:  S Z Salahuddin; D V Ablashi; P D Markham; S F Josephs; S Sturzenegger; M Kaplan; G Halligan; P Biberfeld; F Wong-Staal; B Kramarsky
Journal:  Science       Date:  1986-10-31       Impact factor: 47.728

View more
  17 in total

Review 1.  Human herpesvirus 6.

Authors:  D K Braun; G Dominguez; P E Pellett
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Evaluation of immunoassays for detection of antibodies to human herpesvirus 7.

Authors:  J B Black; T F Schwarz; J L Patton; K Kite-Powell; P E Pellett; S Wiersbitzky; R Bruns; C Müller; G Jäger; J A Stewart
Journal:  Clin Diagn Lab Immunol       Date:  1996-01

3.  Induction of G protein-coupled peptide receptor EBI 1 by human herpesvirus 6 and 7 infection in CD4+ T cells.

Authors:  H Hasegawa; Y Utsunomiya; M Yasukawa; K Yanagisawa; S Fujita
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

4.  Functional interaction between human herpesvirus 6 immediate-early 2 protein and ubiquitin-conjugating enzyme 9 in the absence of sumoylation.

Authors:  Andru Tomoiu; Annie Gravel; Robert M Tanguay; Louis Flamand
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

5.  Human CD4+ T cell response to human herpesvirus 6.

Authors:  Maria-D Nastke; Aniuska Becerra; Liusong Yin; Omar Dominguez-Amorocho; Laura Gibson; Lawrence J Stern; J Mauricio Calvo-Calle
Journal:  J Virol       Date:  2012-02-22       Impact factor: 5.103

6.  Physical and genetic maps of the human herpesvirus 7 strain SB genome.

Authors:  G Dominguez; J B Black; F R Stamey; N Inoue; P E Pellett
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

7.  Phenotypic and functional alterations of dendritic cells induced by human herpesvirus 6 infection.

Authors:  Miki Kakimoto; Atsuhiko Hasegawa; Shigeru Fujita; Masaki Yasukawa
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

8.  Immunotherapeutic strategies to prevent and treat human herpesvirus 6 reactivation after allogeneic stem cell transplantation.

Authors:  Ulrike Gerdemann; Laura Keukens; Jacqueline M Keirnan; Usha L Katari; Chinh T Q Nguyen; Anne P de Pagter; Carlos A Ramos; Alana Kennedy-Nasser; Stephen M Gottschalk; Helen E Heslop; Malcolm K Brenner; Cliona M Rooney; Ann M Leen
Journal:  Blood       Date:  2012-11-14       Impact factor: 22.113

Review 9.  Classification of HHV-6A and HHV-6B as distinct viruses.

Authors:  Dharam Ablashi; Henri Agut; Roberto Alvarez-Lafuente; Duncan A Clark; Stephen Dewhurst; Dario DiLuca; Louis Flamand; Niza Frenkel; Robert Gallo; Ursula A Gompels; Per Höllsberg; Steven Jacobson; Mario Luppi; Paolo Lusso; Mauro Malnati; Peter Medveczky; Yasuko Mori; Philip E Pellett; Joshua C Pritchett; Koichi Yamanishi; Tetsushi Yoshikawa
Journal:  Arch Virol       Date:  2013-11-06       Impact factor: 2.574

10.  Development of virus-specific CD4+ and CD8+ regulatory T cells induced by human herpesvirus 6 infection.

Authors:  Fang Wang; Jing Chi; Guangyong Peng; Feng Zhou; Jinfeng Wang; Lingyun Li; Dongju Feng; Fangyi Xie; Bin Gu; Jian Qin; Yun Chen; Kun Yao
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.